Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease
暂无分享,去创建一个
[1] Jackson T. Wright,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American College of Cardiology.
[2] Douglas E Schaubel,et al. US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] C. Gadegbeku,et al. Hypertension in African Americans , 2017, Current Cardiology Reports.
[4] Li-Chia Chen,et al. Exploring factors associated with patients’ adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom , 2017, Journal of hypertension.
[5] P. Fadel,et al. Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms , 2017, International journal of molecular sciences.
[6] N. Samani,et al. Risk Factors for Nonadherence to Antihypertensive Treatment , 2017, Hypertension.
[7] A. Garg,et al. Quality of Care for Patients With Chronic Kidney Disease in the Primary Care Setting: A Retrospective Cohort Study From Ontario, Canada , 2017, Canadian journal of kidney health and disease.
[8] M. Fornage,et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.
[9] V. Negri,et al. Short-Term Local Adaptation of Historical Common Bean (Phaseolus vulgaris L.) Varieties and Implications for In Situ Management of Bean Diversity , 2017, International journal of molecular sciences.
[10] B. Falkner,et al. Hypertension in Chronic Kidney Disease. , 2016, Advances in experimental medicine and biology.
[11] E. Argulian,et al. Racial and Ethnic Differences in Antihypertensive Medication Use and Blood Pressure Control Among US Adults With Hypertension: The National Health and Nutrition Examination Survey, 2003 to 2012 , 2017, Circulation. Cardiovascular quality and outcomes.
[12] C. McNaughton,et al. Asymptomatic Elevated BP and the Hypertensive Insurgency , 2016, Current Hypertension Reports.
[13] M. Stowasser,et al. Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison , 2016, Current Hypertension Reports.
[14] Mahboob Rahman,et al. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study , 2016, Hypertension.
[15] M. Bots,et al. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease , 2015, Hypertension.
[16] G. Bakris,et al. The double challenge of resistant hypertension and chronic kidney disease , 2015, The Lancet.
[17] N. Oestreicher,et al. Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors. , 2015, The American journal of managed care.
[18] E. Lerma,et al. Cardiovascular disease and chronic kidney disease. , 2015, Disease-a-month : DM.
[19] R. Agarwal,et al. Thiazide Diuretics in Chronic Kidney Disease , 2015, Current Hypertension Reports.
[20] A. Bomback,et al. Definition, identification and treatment of resistant hypertension in chronic kidney disease patients. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] Jackson T. Wright,et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.
[22] C. van Weel,et al. Effect of shared care on blood pressure in patients with chronic kidney disease: a cluster randomised controlled trial. , 2013, The British journal of general practice : the journal of the Royal College of General Practitioners.
[23] S. Oparil,et al. Prevalence of apparent treatment-resistant hypertension among individuals with CKD. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[24] H. Tighiouart,et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.
[25] R. Fluck,et al. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care , 2013, BMC Family Practice.
[26] R. Minutolo,et al. Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients. , 2013, Journal of the American College of Cardiology.
[27] M. Ruzicka,et al. Pharmacologic Treatment of Hypertension in Patients With Chronic Kidney Disease , 2013, American Journal of Cardiovascular Drugs.
[28] A. Lasaridis,et al. The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review , 2013, Hypertension Research.
[29] Brenda R. Hemmelgarn,et al. Notice , 2012, Kidney International Supplements.
[30] Li-yan Wang,et al. Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study , 2013, International Urology and Nephrology.
[31] B. Altun,et al. Major Barriers against Renin–Angiotensin–Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3–5 in Clinical Practice: A Safety Concern? , 2012, Renal failure.
[32] R. Agarwal,et al. Thiazide diuretics in advanced chronic kidney disease. , 2012, Journal of the American Society of Hypertension : JASH.
[33] M. Weir,et al. Thiazide and Thiazide-like Diuretics: An Opportunity to Reduce Blood Pressure in Patients with Advanced Kidney Disease , 2012, Current Hypertension Reports.
[34] L. Pilotto,et al. Electronic records suggest suboptimal management of chronic kidney disease in general practice. , 2012, The Australian journal of rural health.
[35] M. Raebel. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. , 2012, Cardiovascular therapeutics.
[36] Jackson T. Wright,et al. Evidence-Based Guideline for the Management of High Blood Pressure in Adults , 2012 .
[37] P. Zamboli,et al. Burden of Resistant Hypertension in Hypertensive Patients with Non-Dialysis Chronic Kidney Disease , 2011, Kidney and Blood Pressure Research.
[38] David W. Bates,et al. Primary Care Management of Chronic Kidney Disease , 2011, Journal of General Internal Medicine.
[39] M. Rolfe,et al. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[40] D. Wheeler,et al. Blood pressure control in CKD patients: why do we fail to implement the guidelines? , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[41] Jackson T. Wright,et al. ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study , 2010 .
[42] D. Goff,et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.
[43] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.